Akèy › Fibroz sistik › Alabama › Birmingham
Etid klinik pou Fibroz sistik nan Birmingham, AL
16 etid pou Fibroz sistik ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Ap rekrite
- The Children's Hospital Alabama & University of Alabama at Birmingham, Birmingham
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Ap rekriteEtid obsèvasyon
- The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Ap rekriteFaz 4
- The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
4D-710 in Adult Patients With Cystic Fibrosis
Ap rekriteFaz 2
- University of Alabama Child Health Research Unit, Birmingham
Ensuring Access to Optimal Therapy in CF: The ENACT Study
Ap rekriteFaz 4
- The University of Alabama at Birmingham, Birmingham
Rare CFTR Mutation Cell Collection Protocol (RARE)
Ap rekriteEtid obsèvasyonMande peman pou patisipan yo
- University of Alabama at Birmingham, Birmingham
Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Alabama at Birmingham (UAB)/Children's of Alabama, Birmingham
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Alabama at Birmingham, Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Ap rekriteEtid obsèvasyon
- University of Alabama at Birmingham, Birmingham
Personalized Theratyping Trial
Ap rekriteFaz 1 bonè
- University of Alabama at Birmingham, Birmingham
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Ap rekrite
- University of Alabama-Birmingham, Birmingham
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Ap rekriteEtid obsèvasyon
- University of Alabama-Birmingham, Birmingham
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Ap rekriteEtid obsèvasyon
- University of Alabama at Birmingham, Birmingham
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
Ap rekriteFaz 1
- University of Alabama at Birmingham, Birmingham
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Ap rekriteEtid obsèvasyon
- The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Ap rekriteFaz 2
- University of Alabama at Birmingham, Birmingham
Etid Fibroz sistik nan lòt vil
- Boston, MA17 etid
- Philadelphia, PA15 etid
- Kansas City, KS13 etid
- Seattle, WA12 etid
- Baltimore, MD12 etid
- Denver, CO11 etid
- Dallas, TX11 etid
- Pittsburgh, PA11 etid
- Cincinnati, OH10 etid
- Los Angeles, CA9 etid
- Aurora, CO9 etid
- Charleston, SC8 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)31 etid
- Kansè nan tete24 etid
- Kansè ovè23 etid
- Obèsite23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Dyabèt Tip 216 etid
- Kansè Endomèt16 etid
- Sipwa16 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.